UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Decreased by Chesapeake Wealth Management

Chesapeake Wealth Management lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 4,596 shares of the healthcare conglomerate’s stock after selling 57 shares during the quarter. Chesapeake Wealth Management’s holdings in UnitedHealth Group were worth $2,325,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Mitchell & Pahl Private Wealth LLC raised its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Mitchell & Pahl Private Wealth LLC now owns 8,826 shares of the healthcare conglomerate’s stock valued at $4,465,000 after acquiring an additional 39 shares during the last quarter. Pure Financial Advisors LLC raised its position in shares of UnitedHealth Group by 2.9% during the 4th quarter. Pure Financial Advisors LLC now owns 3,674 shares of the healthcare conglomerate’s stock valued at $1,858,000 after acquiring an additional 102 shares during the last quarter. Tudor Financial Inc. grew its holdings in shares of UnitedHealth Group by 15.4% in the 4th quarter. Tudor Financial Inc. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $899,000 after buying an additional 237 shares during the period. Addenda Capital Inc. grew its holdings in shares of UnitedHealth Group by 5.5% in the 4th quarter. Addenda Capital Inc. now owns 27,003 shares of the healthcare conglomerate’s stock valued at $13,660,000 after buying an additional 1,416 shares during the period. Finally, CMH Wealth Management LLC boosted its stake in UnitedHealth Group by 1.8% in the 4th quarter. CMH Wealth Management LLC now owns 13,612 shares of the healthcare conglomerate’s stock worth $6,886,000 after purchasing an additional 238 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. TD Cowen raised their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $510.03 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The firm has a 50 day simple moving average of $549.37 and a 200-day simple moving average of $563.70. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.